Roger M Vilardaga
Assistant Professor in Psychiatry and Behavioral Sciences

Roger Vilardaga, Ph.D. is an Assistant Professor at the Department of Psychiatry and Behavioral Sciences at Duke University. He is also Affiliate Professor a the Department of Human Centered Design and Engineering at the University of Washington. Roger studied psychology at the Universitat de Barcelona and received his doctoral degree in clinical psychology from the University of Nevada, Reno. He has contributed to the study and development of several digital interventions, including Mindful Daily, SmartQuit, Tummy Trials, Eyes Free Yoga, Mindful Powers, and Pain Tracker Self Management. He created and designed Learn to Quit, the first NIH-funded digital therapeutic to deliver smoking cessation treatment for individuals with serious mental illness. This app won the Gold W3 Award in 2016 by the Academy of Interactive and Visual Arts and the Silver Davey International Award in 2016 for best wellness and health app. His work has been featured in FastCompany, The Drum, Seattle K5 News and Psychiatric News. His lab has been funded by the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer and Duke University.

He directs the Access to Behavioral Health for All (ABHA) Lab at Duke's Center for Addition Science and Technology. The focus of the ABHA Lab is to ideate, develop, and test digital behavioral health interventions for underserved populations, such as individuals who experience persistent mental health symptoms, addiction, or chronic pain. The lab specializes in: (1) designing digital tools to foster behavioral health and psychological resilience, and (2) the application of rigorous strategies to evaluate them. The lab uses a multi-method approach that includes user-centered design research, small-n experimental designs, clinical trials methodology, and digital phenotyping to better understand the behavior of digital therapeutics users.

Roger has served as ad-hoc reviewer for more than 25 scientific journals and 4 granting institutions (including the US's Center for Scientific Review), and has received grant funding from the National Institute on Drug Abuse, the University of Washington Innovation Award, Pfizer, the National Cancer Institute, and Duke University.

Current Appointments & Affiliations

Contact Information

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.